You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Novo Nordisk shares tumble as data on weight-loss drug trial disappoints ○

found 2024 › Dec › 20 (Fri) @ 18:41 UTC

Obesity treatment CagriSema misses goal of 25% reduction in body weight